These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8877264)

  • 1. Post-myocardial infarction trials: beta blockers, antiarrhythmics, thrombolytics.
    Anderson JL
    Control Clin Trials; 1996 Jun; 17(3 Suppl):17S-27S. PubMed ID: 8877264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.
    Singh BN
    Am J Cardiol; 1990 Sep; 66(9):9C-20C. PubMed ID: 1699400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers and amiodarone for the primary prevention of sudden cardiac death.
    Frankenberger O; Steinberg JS
    Curr Cardiol Rep; 1999 Nov; 1(4):274-81. PubMed ID: 10980854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmic risk stratification of post-myocardial infarction patients.
    Naccarella F; Lepera G; Rolli A
    Curr Opin Cardiol; 2000 Jan; 15(1):1-6. PubMed ID: 10666655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period.
    Hjalmarson A
    Am J Cardiol; 1997 Nov; 80(9B):35J-39J. PubMed ID: 9375948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.
    Yap YG; Camm AJ
    Am J Cardiol; 1999 Nov; 84(9A):83R-89R. PubMed ID: 10568665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators.
    Boutitie F; Boissel JP; Connolly SJ; Camm AJ; Cairns JA; Julian DG; Gent M; Janse MJ; Dorian P; Frangin G
    Circulation; 1999 May; 99(17):2268-75. PubMed ID: 10226092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials of antiarrhythmic drugs in postmyocardial infarction and congestive heart failure patients.
    Camm AJ; Yap YG
    J Cardiovasc Pharmacol Ther; 2001 Jan; 6(1):99-106. PubMed ID: 11452341
    [No Abstract]   [Full Text] [Related]  

  • 11. [Secondary prevention in the post-infarction period].
    Corea L; Bentivoglio M
    Cardiologia; 1989 Feb; 34(2):127-33. PubMed ID: 2567624
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of antiarrhythmics in the post-infarction period].
    Dinanian S
    Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):65-9. PubMed ID: 10816803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of therapeutic interventions in myocardial infarction. Emphasis on secondary prevention.
    Hinstridge V; Speight TM
    Drugs; 1991; 42 Suppl 2():8-20. PubMed ID: 1718703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of amiodarone on mortality.
    Landray MJ; Kendall MJ
    Lancet; 1998 Feb; 351(9101):523. PubMed ID: 9482474
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-Adrenergic blockers as antiarrhythmic and antifibrillatory compounds: an overview.
    Singh BN
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S3-S14. PubMed ID: 15965570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Magnesium sulfate in acute myocardial infarction].
    Balli E; Giomi A; Del Citerna F
    G Ital Cardiol; 1995 Nov; 25(11):1425-32. PubMed ID: 8682239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class III Antiarrhythmics: put to the SWORD?
    Cobbe SM
    Heart; 1996 Feb; 75(2):111-3. PubMed ID: 8673743
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results.
    Maggioni AP; Zuanetti G; Franzosi MG; Rovelli F; Santoro E; Staszewsky L; Tavazzi L; Tognoni G
    Circulation; 1993 Feb; 87(2):312-22. PubMed ID: 8093865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy to reduce arrhythmic mortality.
    Vora A; Kulkarni S
    Indian Heart J; 2014; 66 Suppl 1(Suppl 1):S113-9. PubMed ID: 24568822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of carvedilol arrhythmia data in clinical trials.
    Kowey PR
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S59-68. PubMed ID: 15965573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.